Bluejay Therapeutics
Marcus Wong is an experienced leader in the pharmaceutical industry, currently serving as Senior Director of Drug Product at Bluejay Therapeutics since March 2025. Prior experience includes serving as Director of CMC Drug Product Development at Allakos Inc, where a comprehensive CMC strategy was established that advanced programs from concept to clinical supply readiness. Previous roles include leading Drug Product CMC development for BioMarin Pharmaceutical Inc.'s Gene Therapy Platform and developing monoclonal antibodies and vaccines at AstraZeneca. Marcus started a career at Aerotek as a Contractor for MedImmune Vaccines, showcasing a strong foundation in process development. Marcus holds a degree from the University of California, Davis.
This person is not in any teams
This person is not in any offices